Menlo Park, CA, United States of America

Christopher J Emig

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.5

ph-index = 1


Company Filing History:


Years Active: 2020-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Christopher J Emig: Pioneering Antibody Research

Introduction

Christopher J Emig, based in Menlo Park, California, is a notable inventor known for his contributions to the field of antibody research, particularly focused on combating SARS-CoV-2. With a total of three patents to his name, Emig's work serves to advance the understanding and treatment of viral infections through innovative immune binding proteins.

Latest Patents

Among Christopher J Emig's latest patents is a significant innovation titled "Antibodies for SARS-CoV-2 and uses thereof." This patent primarily pertains to immune binding proteins and outlines methods for acquiring these proteins from genomic and other sources. Additionally, it details anti-SARS-CoV-2 antibodies obtained from individuals who developed immunity to the virus. The patent also elaborates on methods of utilizing these antibodies to neutralize SARS-CoV-2 and offers potential treatments leveraging their binding capabilities. Another interesting patent he holds focuses on "Methods for isolating immune binding proteins," which describes ways to obtain these proteins while ensuring the natural multimeric association of chains is preserved. This approach leads to enriched libraries of immune binding proteins that possess valuable binding properties.

Career Highlights

Christopher J Emig has made significant strides in his professional journey, working with innovative companies like Augmenta Bioworks, Inc. and Augmenta Biosciences, Inc. His expertise in the field has enabled him to contribute meaningfully to the advancements in antibody research and therapeutic applications.

Collaborations

Throughout his career, Emig has had the opportunity to collaborate with notable professionals, including Marco Antonio Mena and Payam Shahi. These partnerships have enhanced his research and development efforts, pushing the boundaries of what can be achieved in immunological sciences.

Conclusion

Christopher J Emig stands out as an influential inventor whose work is making a notable impact in the fight against viral infections. His patents, particularly those relating to SARS-CoV-2, underscore his commitment to advancing medical science through innovation and collaboration. As researchers and companies continue to build upon his findings, the future of antibody therapies looks promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…